178 related articles for article (PubMed ID: 16497823)
1. NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey.
Pagano L; Gallamini A; Trapè G; Fianchi L; Mattei D; Todeschini G; Spadea A; Cinieri S; Iannitto E; Martelli M; Nosari A; Bona ED; Tosti ME; Petti MC; Falcucci P; Montanaro M; Pulsoni A; Larocca LM; Leone G;
Ann Oncol; 2006 May; 17(5):794-800. PubMed ID: 16497823
[TBL] [Abstract][Full Text] [Related]
2. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
4. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
Wang B; Lu JJ; Ma X; Guo Y; Lu H; Hong X; Li J
Leuk Lymphoma; 2007 Feb; 48(2):396-402. PubMed ID: 17325902
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features and prognosis of nasal type NK/T cell lymphoma].
Zhang YJ; Hu WH; Liu H; Cheng EC; Ren ZM; Xia YF; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):50-3. PubMed ID: 16737622
[TBL] [Abstract][Full Text] [Related]
6. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
[TBL] [Abstract][Full Text] [Related]
7. Nasal-type NK/T cell lymphoma: clinical features and treatment outcome.
Lee J; Kim WS; Park YH; Park SH; Park KW; Kang JH; Lee SS; Lee SI; Lee SH; Kim K; Jung CW; Ahn YC; Ko YH; Park K
Br J Cancer; 2005 Apr; 92(7):1226-30. PubMed ID: 15798768
[TBL] [Abstract][Full Text] [Related]
8. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
10. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
[TBL] [Abstract][Full Text] [Related]
11. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
[TBL] [Abstract][Full Text] [Related]
12. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma.
Takahashi N; Miura I; Chubachi A; Miura AB; Nakamura S
Int J Hematol; 2001 Oct; 74(3):303-8. PubMed ID: 11721967
[TBL] [Abstract][Full Text] [Related]
13. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
14. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
[TBL] [Abstract][Full Text] [Related]
15. Nasal T cell lymphoma: a rare entity.
Kazi M; Ikram M; Junaid M
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S50-1. PubMed ID: 24718007
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of clinical manifestations in nasal NK/T-cell lymphomas].
Wang J; Han D; Yin H
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Feb; 18(2):82-3. PubMed ID: 15362681
[TBL] [Abstract][Full Text] [Related]
17. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
Kim SJ; Oh SY; Hong JY; Chang MH; Lee DH; Huh J; Ko YH; Ahn YC; Kim HJ; Suh C; Kim K; Kim WS
Ann Oncol; 2010 May; 21(5):1058-63. PubMed ID: 19850636
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature.
Youssef YB; Bougmiza I; Bouabid Z; Achour B; Regaieg H; Sriha B; Belkadhi M; Omri HE; Khelif A
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):275-83. PubMed ID: 22991988
[TBL] [Abstract][Full Text] [Related]
19. p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.
Quintanilla-Martinez L; Kremer M; Keller G; Nathrath M; Gamboa-Dominguez A; Meneses A; Luna-Contreras L; Cabras A; Hoefler H; Mohar A; Fend F
Am J Pathol; 2001 Dec; 159(6):2095-105. PubMed ID: 11733360
[TBL] [Abstract][Full Text] [Related]
20. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.
Quintanilla-Martinez L; Franklin JL; Guerrero I; Krenacs L; Naresh KN; Rama-Rao C; Bhatia K; Raffeld M; Magrath IT
Hum Pathol; 1999 Jul; 30(7):849-55. PubMed ID: 10414505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
